Browse studies

Find your next paid study

5 recruiting studies matching your filters

Phase 1 Pilot Study of Bioengineered Penile Tissue Constructs in Subjects With Irreversibly Damaged Penile Corpora

The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of compl…

Urologic DiseasesMale Urogenital DiseasesPenile Diseases+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT03463239

Phase 4

Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome

This a single-center, prospective, exploratory study. Patients with metastatic castration-resistant prostate cancer (mCRPC) scheduled to undergo Lutetium label…

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more

Estimated

~$25 – $1,500

Actual pay is set by the research site.

VA Greater Los Angeles Healthcare SystemNCT06706921

A Non-Significant Risk Specimen Collection Study to Obtain Vaginal Swab Samples for Algorithm Development and Testing

In this pilot study, prospectively acquired clinician-collected and participant-collected vaginal swab specimens will be obtained from up to 1000 individuals w…

Bacterial InfectionsBacterial Infections and MycosesInfections+10 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Nanopath, IncNCT07607470

Phase 1

A Phase 1 Pilot Safety and Feasibility Study of Autologous Engineered Urethral

This is a Phase I clinical study to determine the safety and efficacy of using autologous, engineered urethral constructs for the treatment of urethral strictu…

Urologic DiseasesMale Urogenital DiseasesUrethral Stricture+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT03258658

Phase 1

A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combi…

mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, MaleUrogenital Diseases, Male+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Celcuity IncNCT06190899